Literature DB >> 16708251

Contribution of NMR spectroscopy to the differential diagnosis of a recurrent cranial mass 7 years after irradiation for a pediatric ependymoma.

Isabelle Rutten1, Daniel Raket, Nadine Francotte, Pierre Philippet, Shih-Li Chao, Marc Lemort.   

Abstract

CASE REPORT: We describe the case of a 5-year-old-boy who underwent surgery and focal radiotherapy for an anaplastic ependymoma of the fourth ventricle. One year later, a spinal metastasis was treated the same way. Six years later, a 16-mm lesion was found on a control MRI in the posterior fossa. To help the differential diagnosis between a relapse, a radio-induced modification, and a new tumor, magnetic resonance spectroscopy was performed. The main findings were a peak at the expected resonance frequency of reduced glutathione, a prominent peak of glutamate/glutamine compounds, a low N-acetylaspartate, and the absence of elevated choline. These findings were suggestive of a meningioma, although the latency between irradiation and development of the lesion was quite short. The diagnosis was confirmed by the pathological examination.
CONCLUSION: This case exemplifies the fact that magnetic resonance spectroscopy provides useful biochemical information in such a clinical setting.

Entities:  

Mesh:

Year:  2006        PMID: 16708251     DOI: 10.1007/s00381-006-0111-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas.

Authors:  C Majós; J Alonso; C Aguilera; M Serrallonga; S Coll; J J Acebes; C Arús; J Gili
Journal:  Neuroradiology       Date:  2003-02-19       Impact factor: 2.804

Review 2.  [Radiation-induced meningioma 20 years after operation and high-dose irradiation of an ependymoma].

Authors:  D Daentzer; D K Böker
Journal:  Zentralbl Neurochir       Date:  1999

Review 3.  Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.

Authors:  P Strojan; M Popović; B Jereb
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

4.  Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE.

Authors:  Carles Majós; Margarida Julià-Sapé; Juli Alonso; Marta Serrallonga; Carles Aguilera; Juan J Acebes; Carles Arús; Jaume Gili
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

5.  Improved selectivity of double quantum coherence filtering for the detection of glutathione in the human brain in vivo.

Authors:  A H Trabesinger; P Boesiger
Journal:  Magn Reson Med       Date:  2001-04       Impact factor: 4.668

Review 6.  Epidemiology of intracranial meningioma.

Authors:  W T Longstreth; L K Dennis; V M McGuire; M T Drangsholt; T D Koepsell
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

7.  Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms.

Authors:  V Tugnoli; M R Tosi; G Barbarella; R Ricci; M Leonardi; F Calbucci; A Bertoluzza
Journal:  Oncol Rep       Date:  1998 Sep-Oct       Impact factor: 3.906

8.  Meningiomas in childhood.

Authors:  V R Kolluri; D R Reddy; P K Reddy; M R Naidu; S B Rao; C Sumathi
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

9.  Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS.

Authors:  K S Opstad; S W Provencher; B A Bell; J R Griffiths; F A Howe
Journal:  Magn Reson Med       Date:  2003-04       Impact factor: 4.668

10.  Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.

Authors:  M Harada; M Tanouchi; H Nishitani; H Miyoshi; K Bandou; S Kannuki
Journal:  Jpn J Cancer Res       Date:  1995-03
View more
  1 in total

Review 1.  Dural masses: meningiomas and their mimics.

Authors:  Daniel Lyndon; Joseph A Lansley; Jane Evanson; Anant S Krishnan
Journal:  Insights Imaging       Date:  2019-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.